KangBingDuKouFuYe (KBDKFY) is widely used to treat inffuenza, upper respiratory tract infections, mumps and other diseases.
Due to their diverse active ingredients, it is believed that they may have excellent anti-inflammatory, antibacterial and antiviral
effects. Therefore, we believe they may have multiple therapeutic targets for throat inflammation caused by bacterial or viral
infections. This study utilizes network pharmacology methods to analyze the therapeutic effects of KBDKFY on Bacterial Pharyngeal
Tonsillitis and Viral Pharyngitis, aiming to identify its active ingredients, action targets and related pathways through molecular
docking. Additionally, it determines the afffnity between the main active ingredient and the core target before conducting in vitro
bacteriostatic tests. The analysis results show that KBDKFY contains multiple active ingredients and potential targets for treating
Bacterial Pharyngeal Tonsillitis and Viral Pharyngitis. KEGG enrichment analysis indicates that KBDKFY may have therapeutic
effects on these conditions through pathways such as pathways in cancer, Kaposi sarcoma-associated herpesvirus infection, PI3K-Akt
signaling pathway, and others. This provides a theoretical basis for further exploring pharmacological effects and clinical applications
of KBDKFY.
